Industrias Penoles saw no growth in patent filings and highest growth of 0.99% in grants in June in Q2 2024. Compared to Q1 2024, Q2 2024 saw no growth in patent filings and grants by 0.99%. GlobalData’s DataBook provides a comprehensive analysis of Industrias Penoles‘s patent filings and grants. Buy the databook here.
Industrias Penoles has been focused on protecting inventions in European Patent Office(EPO) with one publication in Q2 2024
The European Patent Office(EPO) Patent Office dominates the patent grants with nearly 100% of grants. The European Patent Office(EPO) patent Office are among the top ten patent offices where Industrias Penoles is filings its patents. Among the top granted patent authorities, Industrias Penoles has 100% of its grants in European Patent Office(EPO).
Bayer and IBIDEN could be the strongest competitors for Industrias Penoles
Patents related to nanomedicine and nano tech lead Industrias Penoles's portfolio
Industrias Penoles has the highest number of patents in nanomedicine followed by, nano tech. For nanomedicine no patents were filed and 50% of patents were granted in Q2 2024.
Biocides related patents lead Industrias Penoles portfolio
Industrias Penoles has highest number of patents in biocides.
For comprehensive analysis of Industrias Penoles's filings and grants, buy the databook here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.